These differences influence how GLP-1 therapies are introduced, titrated, and supported over time
Data collection included patient-reported information collected via questionnaires, either online or on paper, with assistance from research staff and data extraction from electronic medical records
GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity
Beyond those uses, Jaisinghani says researchers are studying GLP-1 drugs for conditions including fatty liver disease (MASH) and chronic kidney disease in people with type 2 diabetes
The weight loss figures referenced on this website are based on self-reported data from altRx members and are not derived from clinical trials or peer-reviewed studies
Counterfeit pens have been found to contain incorrect substances, including insulin, which can cause life-threatening low blood sugar in people who dont have diabetes